(Q40377581)

20 September 2017

Factor VIII-bypassing activity of bovine tissue factor using the canine hemophilic model (English)

1 reference

20 September 2017

0 references

Coagulation factor VIII

0 references

author name string

O'Brien DP

1

1 reference

20 September 2017

Giles AR

2

1 reference

20 September 2017

Tate KM

3

1 reference

20 September 2017

Vehar GA

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 July 1988

1 reference

Journal of Clinical Investigation

20 September 2017

1 reference

20 September 2017

82

1 reference

20 September 2017

1

1 reference

20 September 2017

206-211

1 reference

20 September 2017

Tissue factor revisited.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Regulation of the Initiation of Coagulation by Factor VII

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Affinity purification of human tissue factor: interaction of factor VII and tissue factor in detergent micelles

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

By what mechanisms could prothrombin complex concentrates promote factor VIII bypassing activity in vivo?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Hazards of prothrombin-complex concentrates in treatment of hemophilia.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Induction of tolerance to factor VIII in a child with a high-titer inhibitor: in vitro and in vivo observations

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Prothrombin Concentrates in Treatment of Christmas Disease and Allied Disorders

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Failure of combined factor VIII and cyclophosphamide to suppress antibody to factor VIII in hemophilia

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

A potential new procedure for removing anti-factor VIII antibodies from hemophilic plasma

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Purification of human brain tissue factor.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

A canine model of hemophilic (factor VIII:C deficiency) bleeding

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Hemophiliacs with inhibitors: therapeutic options

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

Treatment of a high titer anti-factor-VIII antibody by continuous factor VIII administration: report of a case.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

There is no correlation between vitamin K dependent coagulant content and clinical effectiveness of activated and standard factor IX complex concentrates.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303495

[Rapid physiological coagulation method in determination of fibrinogen]

20 August 2018

1 reference

12 December 2020

Intravascular coagulation with use of human prothrombin complex concentrates

1 reference

12 December 2020

1 reference

12 December 2020

Purification and characterization of bovine tissue factor

1 reference

12 December 2020

Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor

1 reference

12 December 2020

Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII

1 reference

12 December 2020

Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component

1 reference

12 December 2020

Management of haemophilia A with antibodies--the effect of combined treatment with factor VIII, hydrocortisone and cyclophosphamide

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI113571

1 reference

20 September 2017

1 reference

20 September 2017

PubMed publication ID

3134399

1 reference